HKPD MEXC RealStocks
Own real HKPD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-14 04:49:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.59, with a market capitalization of $3.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.34 to $29.00. This page covers its latest market performance, valuation, price trends and company information.
$3.77M | |
$1.52 | |
$1.59 | |
$1.51 | |
$1.53 | |
6.84K | |
184.46K | |
-- | |
$29.00 | |
$1.34 | |
-- | |
-- |
Cellyan Biotechnology Co., Ltd (HKPD) last closed at $1.59 as of 2026-11-14 00:31:00, up 5.88% ($0.09) from the previous close of $1.53.
During the latest regular trading session, HKPD traded between $1.51 and $1.59, with a volume of 6.84K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Cellyan Biotechnology Co., Ltd (HKPD) moved from $1.36 to $1.59, representing a gain of 16.54% ($0.22).
The stock traded between $1.34 and $1.92 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 17.86 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.9%
HKPD is currently trading at $1.59, placing it 0.9% of the way from its 52-week low of $1.34 to its 52-week high of $29.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellyan Biotechnology Co., Ltd (HKPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HKPD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HKPD shares and USD.
HKPD Shares to USD
1.00 HKPD shares = 1.585 USD
Calculations are estimates based on the latest available price and are for reference only.